Glenmark Pharmaceuticals Ltd

NSE: GLENMARK BSE: 532296

₹2209.60

(1.52%)

Wed, 17 Jun 2026, 05:23 pm

MTF 5xInvest in Glenmark Pharmaceuticals Ltd with 5x Leverage Buy with MTF

Market Cap (in Cr)61478.86

PE Ratio45.80

Dividend0.23

Health Technology

Pharmaceuticals: Major

24.5K

Glenmark Pharmaceuticals Ltd About

Glenmark Pharmaceuticals is engaged in the business of development, manufacturing and marketing of pharmaceutical products both formulation and active pharmaceuticals ingredient to regulated and semi-regulated markets.

Industry

Pharmaceuticals - Indian - Bulk Drugs & Formln

Founded

1977

Headquarters

CEO

Glenn Saldanha

Employees

Contact

Website

http://www.glenmarkpharma.com

complianceofficer@glenmarkpharma.com

Phone

91-22-40189999

Location

B/2 Mahalaxmi Chambers, 22 Bhulabhai Desai Road, Mumbai, Maharashtra, 400026

Executives

Glenn Saldanha

Chairman / Executive Director / M D / Promoter

Cheryl Pinto

ED / WTD / Promoter

Anurag Mantri

ED / President / Global CFO

B E Saldanha

Non Executive Director

Sona Saira Ramasastry

Independent Non Exe. Director

Dipankar Bhattacharjee

Independent Non Exe. Director

V R Iyer

Independent Non Exe. Director

Pradeep Kumar Sinha

Independent Non Exe. Director

Harish Kuber

Company Sec. & Compli. Officer